Correction To: An Adapted European Leukemianet Genetic Risk Stratification for Acute Myeloid Leukemia Patients Undergoing Allogeneic Hematopoietic Cell Transplant. a CIBMTR Analysis

Authors

• Antonio M. Jimenez Jimenez, Division of Transplantation and Cellular Therapy, University of Miami Miller School of Medicine, Miami, FL, USA. amjimenez@med.miami.edu.
• Marcos De Lima, Department of Medicine, Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, OH, USA.
• Krishna V. Komanduri, Division of Transplantation and Cellular Therapy, University of Miami Miller School of Medicine, Miami, FL, USA.
• Trent P. Wang, Division of Transplantation and Cellular Therapy, University of Miami Miller School of Medicine, Miami, FL, USA.
• Mei-Jie Zhang, (CIBMTR)® Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.Follow
• Karen Chen, (CIBMTR)® Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
• Hisham Abdel-Azim, Division of Hematology, Oncology and Blood & Marrow Transplantation, Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, CA, USA.Follow
• Muhammad Bilal Abid, Divisions of Hematology/Oncology & Infectious Diseases, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
• Mahmoud Aljurf, Department of Oncology, King Faisal Specialist Hospital Center & Research, Riyadh, Saudi Arabia.Follow
• Hassan Alkhateeb, Mayo Clinic Rochester, Rochester, MN, USA.
• Amer Assal, Columbia University Irving Medical Center, Department of Medicine, Bone Marrow Transplant and Cell Therapy Program, New York, NY, USA.Follow
• Ulrike Bacher, Department of Hematology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.Follow
• Frédéric Baron, CHU and University of Liege, Liege, Belgium.
• Minoo Battiwalla, Sarah Cannon Blood Cancer Network, Nashville, TN, USA.
• Amer Beitinjaneh, Division of Transplantation and Cellular Therapy, University of Miami Miller School of Medicine, Miami, FL, USA.
• Nelli Bejanyan, Department of Blood & Marrow Transplant and Cellular Immunotherapy (BMT CI), Moffitt Cancer Center, Tampa, FL, USA.
• Vijaya Raj Bhatt, The Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA.Follow
• Michael Byrne, Vanderbilt University Medical Center, Nashville, TN, USA.
• Jean-Yves Cahn, Department of Hematology, CHU Grenoble Alpes, Université Grenoble Alpes, Grenoble, France.
• Mitchell Cairo, Division of Pediatric Hematology, Oncology and Stem Cell Transplantation, Department of Pediatrics, New York Medical College, Valhalla, NY, USA.Follow
• Paul Castillo, UF Health Shands Children's Hospital, Gainesville, FL, USA.
• Edward Copelan, Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
• Zachariah DeFilipp, Hematopoietic Cell Transplant and Cellular Therapy Program, Massachusetts General Hospital, Boston, MA, USA.
• Miguel Angel Perez, Department of Hematology/Oncology, Hospital Infantil Universitario Niño Jesus, Madrid, Spain.
• Mahmoud Elsawy, Division of Hematology, Department of Medicine, Dalhousie University, Halifax, NS, Canada.
• Robert Peter Gale, Haematology Research Centre, Department of Immunology and Inflammation, Imperial College London, London, UK.
• Biju George, Christian Medical College, Vellore, India.
• Michael R. Grunwald, Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
• Gerhard C. Hildebrandt, Markey Cancer Center, University of Kentucky, Lexington, KY, USA.
• William J. Hogan, Division of Hematology/BMT, Mayo Clinic, Rochester, MN, USA.
• Christopher G. Kanakry, Experimental Transplantation and Immunotherapy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
• Ankit Kansagra

Author Type(s)

Faculty

DOI

10.1038/s41409-022-01625-6

Journal Title

Bone Marrow Transplantation

First Page

852

Document Type

Article

Publication Date

5-1-2022

Department

Pediatrics

Disciplines

Medicine and Health Sciences

Recommended Citation

Jimenez Jimenez, A. M., De Lima, M., Komanduri, K. V., Wang, T. P., Zhang, M., Chen, K., Abdel-Azim, H., Abid, M. B., Aljurf, M., Alkhateeb, H., Assal, A., Bacher, U., Baron, F., Battiwalla, M., Beitinjaneh, A., Bejanyan, N., Bhatt, V. R., Byrne, M., Cahn, J., Cairo, M., Castillo, P., Copelan, E., DeFilipp, Z., Perez, M. A., Elsawy, M., Gale, R. P., George, B., Grunwald, M. R., Hildebrandt, G. C., Hogan, W. J., Kanakry, C. G., & Kansagra, A. (2022). Correction To: An Adapted European Leukemianet Genetic Risk Stratification for Acute Myeloid Leukemia Patients Undergoing Allogeneic Hematopoietic Cell Transplant. a CIBMTR Analysis. Bone Marrow Transplantation, 57 (5), 852. https://doi.org/10.1038/s41409-022-01625-6